Created in 2013 (United States), CELLTRACKS ANALYZER II own 2466 sister brands and 17477 competing brands. CELLTRACKS ANALYZER II is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York CELLTRACKS ANALYZER II belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(CELLTRACKS ANALYZER II)
over 5 years*
USD 159.07